Back | Next |
home / stock / ikt / ikt message board
Subject | By | Source | When |
---|---|---|---|
Price trading | jedijazz | investorshub | 03/31/2023 2:33:23 PM |
Price trading last trade up | budfoxfun | investorshub | 03/31/2023 12:08:15 PM |
$IKT Anyone hear anything lately? Want to see this one go | estreet7883 | investorshub | 03/31/2023 4:03:31 AM |
The gaining | CarlCarlMcB | investorshub | 03/31/2023 2:45:48 AM |
$IKT bears are running | conix | investorshub | 03/30/2023 10:25:31 PM |
must see | conix | investorshub | 03/30/2023 10:13:17 PM |
$IKT Price gaining last up | kzivann | investorshub | 03/30/2023 5:34:26 PM |
$IKT Lets go go go go... Up up and away we go. | heyitsmeagain | investorshub | 03/30/2023 5:31:24 PM |
$IKT Have a look at this | conix | investorshub | 03/30/2023 2:39:00 PM |
news out | TrendTrade2016 | investorshub | 03/30/2023 1:07:05 PM |
The trading last up | CarlCarlMcB | investorshub | 03/30/2023 11:08:01 AM |
$IKT bulls and bears | heyitsmeagain | investorshub | 03/29/2023 10:10:31 PM |
just the news we needed | heyitsmeagain | investorshub | 03/29/2023 6:52:23 PM |
Thoughts on where this is headed? | jedijazz | investorshub | 03/29/2023 2:40:44 PM |
should we be shorting? | conix | investorshub | 03/29/2023 12:06:24 PM |
$IKT what do you make of this data? | ProfitScout | investorshub | 03/29/2023 1:58:12 AM |
The now last trade up | conix | investorshub | 03/29/2023 12:56:16 AM |
$IKT MomentumIts now | ProfitScout | investorshub | 03/28/2023 2:35:50 PM |
MomentumIts now | INFINITI | investorshub | 03/28/2023 8:51:44 AM |
PPS down on heavy volume again. | kzivann | investorshub | 01/26/2023 1:15:00 PM |
News, Short Squeeze, Breakout and More Instantly...
Inhibikase Therapeutics Inc. Company Name:
IKT Stock Symbol:
NASDAQ Market:
Inhibikase Therapeutics Inc. Website:
BOSTON and ATLANTA, June 17, 2024 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease, Parkinso...
- Company positioning multiple assets for late-stage development across its therapeutic pipeline – BOSTON and ATLANTA, June 05, 2024 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (Inhibikase or Company), a clinical-stage pharmaceutical company developing protein kin...
BOSTON and ATLANTA, May 20, 2024 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease, Parkinson...